National Research (NASDAQ:NRC) Sets New 12-Month Low at $20.41

National Research Co. (NASDAQ:NRC)’s stock price hit a new 52-week low during mid-day trading on Tuesday . The stock traded as low as $20.41 and last traded at $21.63, with a volume of 96255 shares traded. The stock had previously closed at $20.85.

National Research Price Performance

The stock has a market capitalization of $516.46 million, a PE ratio of 16.81 and a beta of 0.49. The company has a debt-to-equity ratio of 0.75, a current ratio of 0.41 and a quick ratio of 0.41. The firm’s 50 day simple moving average is $24.12 and its 200 day simple moving average is $31.99.

National Research Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, October 11th. Stockholders of record on Friday, September 27th will be paid a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date of this dividend is Friday, September 27th. National Research’s dividend payout ratio (DPR) is presently 38.71%.

Institutional Investors Weigh In On National Research

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in NRC. CWM LLC boosted its holdings in National Research by 889.7% in the second quarter. CWM LLC now owns 1,158 shares of the company’s stock valued at $27,000 after acquiring an additional 1,041 shares in the last quarter. Benjamin F. Edwards & Company Inc. boosted its stake in shares of National Research by 860.2% during the 1st quarter. Benjamin F. Edwards & Company Inc. now owns 1,133 shares of the company’s stock valued at $45,000 after purchasing an additional 1,015 shares in the last quarter. Gladius Capital Management LP increased its position in shares of National Research by 59.8% during the fourth quarter. Gladius Capital Management LP now owns 1,326 shares of the company’s stock valued at $52,000 after buying an additional 496 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank raised its stake in National Research by 184.3% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 3,179 shares of the company’s stock worth $126,000 after buying an additional 2,061 shares in the last quarter. Finally, SG Americas Securities LLC purchased a new stake in National Research in the fourth quarter worth about $147,000. 47.26% of the stock is currently owned by institutional investors.

National Research Company Profile

National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.